Inhibition of Nuclear Import of LIMK2 in Endothelial Cells by Protein Kinase C-dependent Phosphorylation at Ser-283

Pankaj Goyal, Dharmendra Pandey, Antje Behring, Wolfgang Siess

Journal of Biological Chemistry · 2005 · 33 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

LIM kinases (LIMKs) are mainly in the cytoplasm and regulate actin dynamics through cofilin phosphorylation. Recently, it has been reported that nuclear localization of LIMKs can mediate suppression of cyclin D1 expression. Using immunofluorescence monitoring of enhanced green fluorescent protein-tagged LIMK2 in combination with photobleaching techniques and leptomycin B treatment, we demonstrate that LIMK2 shuttles between the cytoplasm and the nucleus in endothelial cells. Sequence analysis predicted two PKC phosphorylation sites in LIMK2 but not in LIMK1. One site at Ser-283 is present between the PDZ and the kinase domain, and the other site at Thr-494 is within the kinase domain. Activation of PKC by phorbol ester treatment of endothelial cells stimulated LIMK2 phosphorylation at Ser-283 and inhibited nuclear import of LIMK2 and the PDZ kinase construct of LIMK2 (amino acids 142–638) but not of LIMK1. The PKC-δ isoform phosphorylated LIMK2 at Ser-283 in vitro. Mutational analysis indicated that LIMK2 phosphorylation at Ser-283 but not Thr-494 was functional. Serum stimulation of endothelial cells also inhibited nuclear import of PDZK-LIMK2 by protein kinase C-dependent phosphorylation of Ser-283. Our study shows that phorbol ester and serum stimulation of endothelial cells inhibit nuclear import of LIMK2 but not LIMK1. This effect was dependent on PKC-δ-mediated phosphorylation of Ser-283. Since phorbol ester enhanced cyclin D1 expression and subsequent G1-to-S-phase transition of endothelial cells, we suggest that the PKC-mediated exclusion of LIMK2 from the nucleus might be a mechanism to relieve suppression of cyclin D1 expression by LIMK2. LIM kinases (LIMKs) are mainly in the cytoplasm and regulate actin dynamics through cofilin phosphorylation. Recently, it has been reported that nuclear localization of LIMKs can mediate suppression of cyclin D1 expression. Using immunofluorescence monitoring of enhanced green fluorescent protein-tagged LIMK2 in combination with photobleaching techniques and leptomycin B treatment, we demonstrate that LIMK2 shuttles between the cytoplasm and the nucleus in endothelial cells. Sequence analysis predicted two PKC phosphorylation sites in LIMK2 but not in LIMK1. One site at Ser-283 is present between the PDZ and the kinase domain, and the other site at Thr-494 is within the kinase domain. Activation of PKC by phorbol ester treatment of endothelial cells stimulated LIMK2 phosphorylation at Ser-283 and inhibited nuclear import of LIMK2 and the PDZ kinase construct of LIMK2 (amino acids 142–638) but not of LIMK1. The PKC-δ isoform phosphorylated LIMK2 at Ser-283 in vitro. Mutational analysis indicated that LIMK2 phosphorylation at Ser-283 but not Thr-494 was functional. Serum stimulation of endothelial cells also inhibited nuclear import of PDZK-LIMK2 by protein kinase C-dependent phosphorylation of Ser-283. Our study shows that phorbol ester and serum stimulation of endothelial cells inhibit nuclear import of LIMK2 but not LIMK1. This effect was dependent on PKC-δ-mediated phosphorylation of Ser-283. Since phorbol ester enhanced cyclin D1 expression and subsequent G1-to-S-phase transition of endothelial cells, we suggest that the PKC-mediated exclusion of LIMK2 from the nucleus might be a mechanism to relieve suppression of cyclin D1 expression by LIMK2. Contraction, migration, and proliferation of vascular endothelial cells are essential features of vascular permeability, endothelial repair after injury, and angiogenesis (1Folkman J. Shing Y. J. Biol. Chem. 1992; 267: 10931-10934Abstract Full Text PDF PubMed Google Scholar, 2Jackson D. Volpert O.V. Bouck N. Linzer D.I. Science. 1994; 266: 1581-1584Crossref PubMed Scopus (203) Google Scholar) and are regulated by coordinated changes of actin dynamics (3Tang S. Morgan K.G. Parker C. Ware J.A. J. Biol. Chem. 1997; 272: 28704-28711Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 4van Nieuw Amerongen G.P. Koolwijk P. Versteilen A. van Hinsbergh V.W.M. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 211-217Crossref PubMed Scopus (262) Google Scholar). The LIMK 1The abbreviations used are: LIM domain, acronyms for lim, isl, mec domain; LIMK, LIM kinase; PDZ, PSD-95, disc large, ZO-1; PDZK, EGFP-PDZ-kinase domain construct of LIMK2; PKC, protein kinase C; CRM1, chromosomal region maintenance 1; EGFP, enhanced green fluorescent protein; LMB, leptomycin B; NES, nuclear export signal; NLS, nuclear localization signal; PMA, phorbol 12-myristate 13-acetate; FRAP, fluorescence recovery after photobleaching; FLIP, fluorescence loss in photobleaching; FCS, fetal calf serum. 1The abbreviations used are: LIM domain, acronyms for lim, isl, mec domain; LIMK, LIM kinase; PDZ, PSD-95, disc large, ZO-1; PDZK, EGFP-PDZ-kinase domain construct of LIMK2; PKC, protein kinase C; CRM1, chromosomal region maintenance 1; EGFP, enhanced green fluorescent protein; LMB, leptomycin B; NES, nuclear export signal; NLS, nuclear localization signal; PMA, phorbol 12-myristate 13-acetate; FRAP, fluorescence recovery after photobleaching; FLIP, fluorescence loss in photobleaching; FCS, fetal calf serum. family of proteins, a member of the class of serine/threonine protein kinases, consists of LIMK1 and LIMK2 that specifically phosphorylate and inactivate cofilin, an actin-depolymerizing protein, thereby regulating actin cytoskeleton rearrangement (5Arber S. Barbayannis F.A. Hanser H. Schneider C. Stanyon C.A. Bernard O. Caroni P. Nature. 1998; 393: 805-809Crossref PubMed Scopus (1154) Google Scholar, 6Yang N. Higuchi O. Ohashi K. Nagata K. Wada A. Kangawa K. Nishida E. Mizuno K. Nature. 1998; 393: 809-812Crossref PubMed Scopus (1059) Google Scholar). Other studies showed that cell cycle progression depends on the regulated activity of the LIMK-cofilin system (7Amano T. Kaji N. Ohashi K. Mizuno K. J. Biol. Chem. 2002; 277: 22093-22102Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar, 8Sumi T. Matsumoto K. Nakamura T. Biochem. Biophys. Res. Commun. 2002; 290: 1315-1320Crossref PubMed Scopus (32) Google Scholar). The kinase activity of LIMKs is regulated by members of the RhoGTPase family, Rho, Rac, and CdC42, via their downstream protein kinases Rho kinase and p21-activated kinases 1 and 4. These kinases phosphorylate LIMK1 at Thr-508 in the activation loop of the kinase domain (9Ohashi K. Nagata K. Maekawa M. Ishizaki T. Narumiya S. Mizuno K. J. Biol. Chem. 2000; 275: 3577-3582Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar, 10Edwards D.C. Sanders L.C. Bokoch G.M. Gill G.N. Nat. Cell Biol. 1999; 1: 253-259Crossref PubMed Scopus (841) Google Scholar, 11Dan C. Kelly A. Bernard O. Minden A. J. Biol. Chem. 2001; 276: 32115-32121Abstract Full Text Full Text PDF PubMed Scopus (219) Google Scholar). Rho kinase activates LIMK2 by phosphorylation at Thr-505 (12Sumi T. Matsumoto K. Nakamura T. J. Biol. Chem. 2001; 276: 670-676Abstract Full Text Full Text PDF PubMed Scopus (245) Google Scholar, 13Amano T. Tanabe K. Eto T. Narumiya S. Mizuno K. Biochem. J. 2001; 354: 149-159Crossref PubMed Scopus (136) Google Scholar). Several lines of evidence suggest that LIMKs also have a function in the nucleus. LIMK1 is predominantly localized in the cytoplasm but accumulates in the nucleus, when the cells are treated with the CRM1-dependent export inhibitor, leptomycin B (LMB) (14Yang N. Higuchi O. Mizuno K. Exp. Cell Res. 1998; 241: 242-252Crossref PubMed Scopus (34) Google Scholar). In mouse tissues, various splice forms of LIMK2 have been reported that display an unique cellular localization (15Nunoue K. Ohashi K. Okano I. Mizuno K. Oncogene. 1995; 11: 701-710PubMed Google Scholar, 16Ikebe C. Ohashi K. Mizuno K. Biochem. Biophys. Res. Commun. 1998; 246: 307-312Crossref PubMed Scopus (18) Google Scholar). LIMK2a (full-length) and LIMK2b containing only one LIM domain are localized exclusively in the cytoplasm (17Osada H. Hasada K. Inazawa J. Uchida K. Ueda R. Takahashi T. Takahashi T. Biochem. Biophys. Res. Commun. 1996; 229: 582-589Crossref PubMed Scopus (26) Google Scholar). In contrast, tLIMK2 (testis-specific LIMK2 splice form) lacking both LIM domains was found to be preferentially localized in the nucleus (18Takahashi H. Koshimizu U. Miyazaki J. Nakamura T. Dev. Biol. 2002; 241: 259-272Crossref PubMed Scopus (78) Google Scholar). The phenotype of the LIMK2 knock-out mouse showed a defect in spermatogenesis, suggesting a nuclear function of tLIMK2 in testis (18Takahashi H. Koshimizu U. Miyazaki J. Nakamura T. Dev. Biol. 2002; 241: 259-272Crossref PubMed Scopus (78) Google Scholar). The kinase domain of LIMKs has a unique basic amino acid-rich motif between subdomains VII and VIII. The basic nature of this motif suggests that this may function as a nuclear localization signal (NLS). Moreover, LIMK1 has two export signal sequences within the PDZ domain (14Yang N. Higuchi O. Mizuno K. Exp. Cell Res. 1998; 241: 242-252Crossref PubMed Scopus (34) Google Scholar). The NLS and NES might explain the nucleocytoplasmic shuttling of LIMK1. A recent study shows that the nuclear localization of LIMKs can mediate suppression of Rac/Cdc42-mediated cyclin D1 expression. This effect of LIMKs was independent of cofilin phosphorylation and regulation of actin dynamics (19Roovers K. Klein E.A. Castagnino P. Assoian R.K. Dev. Cell. 2003; 5: 273-284Abstract Full Text PDF PubMed Scopus (46) Google Scholar). In the present study, we addressed the question of whether LIMK2 shuttles between the nucleus and the cytoplasm in endothelial cells and explored possible mechanisms of regulation of LIMK2 nucleocytoplasmic shuttling. We found that LIMK2 shuttles between the cytoplasm and the nucleus in endothelial cells and discovered that PKC inhibits the nuclear import of LIMK2 by phosphorylating the enzyme at Ser-283. PKC-mediated exclusion of LIMK2 from the nucleus might relieve suppression of cyclin D1 expression, leading to G1 phase cell cycle progression. Materials—Phorbol 12-myristate 13-acetate (PMA) and LMB were from Sigma. The recombinant PKCs and the PKC inhibitors and were from was from PKC and and D1 were from Cell was by of Cell of was from Sigma. were by The expression was from of the containing of LIMK2 was by Mizuno The of LIMK2 was by with as a The was and sites of to LIMK2 with The of LIMK1 was by from a of endothelial cell The of LIMK2 and LIMK1 were and sites of (amino acids (amino acids in PDZ kinase (amino acids and kinase domain (amino acids of LIMK2 and PDZ kinase (amino acids of LIMK1. The of kinase were by the as the recombinant LIMK2 in P. the LIMK2 was expression by and the were by of LIMK2 in P. was in P. and the with the protein expression was as the The of cells was in of and of at the cells were at and were in in the was by to protein expression, and the cells were by at at for The cells were with and in with of in was to the and cells were by for 1 with 1 of on Cell were by at at for by at for The was to the at and LIMK2 was to the Cell and endothelial cells were and as E.A. J. PubMed Scopus Google Scholar). cells from were and were at and in endothelial In endothelial cells to were of endothelial cells was by as T. P. A. J. J. 2001; PubMed Scopus Google Scholar) with cells were to by treatment, and with were in in of was with the cell The cells were for and a were at and of endothelial was and cells were to that are for The cells were in endothelial for to and after 1 and The was and endothelial cells with and in an of inhibitor, 1 and for on The were by at for and of protein was to the and for 1 at to the was by the in and containing serum to were with by the of of protein and at for 1 The were by at for and with 1 of The were for In of LIMK2 by and of were from endothelial cells. The were with PKC kinase LIMK2 recombinant were with of PKC at in of containing of and of for were by the of and the for The phosphorylation of LIMK2 was after with PKC and stimulated endothelial cells were in an of of in the were to and to at for at the cell were with and with the and The of the and PKC and D1 The of the was The were with and to The were a analysis of the was the domain The to an of the was by the as a The of phosphorylated were by the of proteins, of in was to are as of independent of cells were in phase by serum cell containing for The to the of cells in phase at this The cells were a in endothelial cell endothelial containing serum The cells were at various and in at for The cells were in of containing FCS, and the was in in and for 1 The cells were a were the of cells were and for in an and cells were with a The cells were the at The was used as a for The function was by a through the the and the were and were to the and The and the of the were by The were in independent with cells in was for and recovery after photobleaching and fluorescence loss in photobleaching analysis was with the as J. J. A Scholar). an with a of was used at it was used at was of an of of photobleaching was at with the nucleus was The recovery of fluorescence was in in The of the of and was and the of the photobleaching was to the for were the as for the and were of cytoplasm was with at The fluorescence in the nucleus of the cell and an cell was LIMK2 between the and the the of LIMK2 in endothelial cells, cells were with an expression LIMK2 with the protein was the cells. The protein was the cytoplasm and the nucleus the of through the nuclear The protein was mainly localized in the cytoplasm and only a was in the nucleus whether LIMK2 shuttles between the nucleus and cytoplasm in endothelial cells, endothelial cells were treated with LMB inhibits the CRM1-dependent export of from the nucleus N. T. Y. M. S. M. Exp. Cell Res. 1998; PubMed Scopus Google Scholar, Y. Chem. Biol. 1997; Full Text PDF PubMed Scopus Google Scholar). LMB treatment, localized exclusively in the nucleus The of was not by the LMB treatment These indicated that the the nucleus and that and of the nucleus. The nucleocytoplasmic shuttling of LIMK2 was by photobleaching techniques in endothelial cells. cells were with the kinase domain construct of LIMK2 between the nucleus and cytoplasm by and showed that between nucleus and analysis after photobleaching of the nucleus showed that the nucleus. The for recovery of fluorescence was These that the within the kinase domain the the nucleus. study whether was from the nucleus to the the analysis was of the cytoplasm of a cell was and fluorescence in the nucleus of the cell was the fluorescence in the nucleus of an cell was The of nuclear fluorescence in the cell In contrast, the nuclear fluorescence in the cell was This indicated that was from the nucleus in endothelial cells. LIM the of it has been reported that LIM domains with the kinase domain of LIMK1 K. Ohashi K. N. Mizuno K. Biochem. J. 1999; PubMed Google Scholar). Since LIMK2 is found mainly in the of endothelial cells, the NLS of LIMK2 in the kinase domain might be by the with the LIM of LIMK2 were with in one both LIM domains were The nuclear localization of domain was the A and This indicated that a in the localization of LIMK2. In contrast, the protein domain was localized mainly in the to the protein, suggesting that the domain not the localization of LIMK2. of LIMK2 LIM domains was in the nucleus of the protein; These that both LIM domains to the localization of LIMK2. was mainly present in the and after LMB treatment, it was exclusively localized in the nucleus of endothelial cells not cells, and cells N. Mizuno K. Biochem. J. 1999; PubMed Scopus (46) Google Scholar). in to of the two LIM domains of LIMK1 not the of LIMK1. The of LIMK1 was localized in the cytoplasm A and This indicated that the nucleocytoplasmic shuttling of LIMK1 and LIMK2 is regulated by LIM domains might inhibit the nuclear import the nuclear export of LIMK2. between two the of nuclear of and endothelial cells were after the of LMB to inhibit nuclear We found that the nuclear fluorescence of as to as the nuclear fluorescence of after LMB These indicated that the LIM domains the of the nuclear import of LIMK2; to inhibit nuclear of LIMK2 when cells were treated for 1 with LMB of on the of of the amino two PKC phosphorylation sites in LIMK2; one site at Ser-283 is between the PDZ and the kinase domain and a site is at Thr-494 in the kinase domain of LIMK2. was PKC phosphorylation site in LIMK1. whether PKC activation the nuclear localization of the of and kinase of LIMK2 in endothelial cells was and after stimulation with PMA, a PKC of stimulation with PMA, the of nuclear to a and and of LIMK2 was to the cytoplasm in cells and and was effect of on the nuclear localization of kinase of LIMK2 and These indicated that PKC activation inhibits the nuclear localization of LIMK2 and that Ser-283 between the PDZ and kinase domain may be the for PKC the phosphorylation Thr-494 in the kinase domain, not to be in the regulation of LIMK2 nucleocytoplasmic shuttling. The localization of of LIMK1 was not by that nucleocytoplasmic shuttling of LIMK1 is not regulated by PKC activation and that the exclusion of LIMK2 from the nucleus is regulated by PKC, two PKC inhibitors were and P. M. J. PubMed Scopus Google Scholar, M. S. J. 1996; PubMed Scopus Google Scholar, M. H. P. H. D. C. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The of to the cytoplasm was by two PKC inhibitors of LIMK2 at Ser-283 in are to protein phosphorylation. the PKC phosphorylation site in a PKC was used H. Y. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar). This with to the for PKC phosphorylation present between the PDZ and kinase domain of LIMK2 whether LIMK2 was phosphorylated by PKC, endothelial cells were treated with PMA, and LIMK2 in endothelial cell was with a and with PKC The phosphorylation of LIMK2 after treatment A and PKC inhibitors and inhibited LIMK2 phosphorylation in cells and cells A and was These that PKC LIMK2 on Ser-283 in endothelial cells. the of the PKC a of was in Ser-283 was to The was endothelial cells, and cells were stimulated with The PKC a of phosphorylation of after stimulation was signal on the of the of in cells cells These that Ser-283 in LIMK2 is phosphorylated in cells. PKC-δ LIMK2 at Ser-283 in whether PKC LIMK2 and to PKC isoform is we in kinase recombinant LIMK2 and of The that only PKC-δ was to phosphorylate LIMK2 that PKC-δ phosphorylated LIMK2 at of and were to in phosphorylation by The demonstrate that PKC-δ phosphorylated but to phosphorylate the of the that PKC-δ LIMK2 at Ser-283. PKC-mediated of but the of whether Ser-283 phosphorylation is for the of LIMK2 from the nucleus to the cytoplasm in cells, Ser-283 was to two acids of the phosphorylation site with two amino acids the phosphorylation of that LIMK2 containing the be containing the be stimulation of cells, was from the nucleus, the nuclear localization of the of was not A and In contrast, of the PKC phosphorylation site the of was from the nucleus to the cytoplasm to the protein after treatment A and In cells with the of the protein was exclusively localized in the cytoplasm to the cells and These indicated that PKC the nuclear of LIMK2 in endothelial cells through phosphorylation of of Ser-283 inhibits nuclear import of after LMB treatment of endothelial cells. cells were with of their and were with for and with LMB at to nuclear of protein was by the nuclear fluorescence at of were localized in the nucleus within 1 of LMB In the nuclear of LIMK2 was after were for the of are of independent Serum of the of PDZK-LIMK2 by C-dependent of evidence for the of the endothelial cells were stimulated with activates as stimulation of endothelial cells, been for inhibited the nuclear of to This effect was by of cells with by of A and These showed that of endothelial cells to present in exclusion of LIMK2 from the nucleus, was by PKC phosphorylation of LIMK2 at Ser-283. PKC-mediated LIMK2 of Ser-283 of exclusion of LIMK2 from the nucleus by PKC activation may be to of nuclear export of nuclear between two endothelial cells were treated with PMA, and LMB was to inhibit nuclear The of nuclear fluorescence of after LMB showed a of nuclear of LIMK2 after were in cells with the of These indicated that phosphorylation of Ser-283 by PKC inhibits the nuclear import of LIMK2. PKC Activation D1 and of it has been reported that nuclear localization of LIMKs can mediate suppression of cyclin D1 expression and of G1 phase cell cycle progression (19Roovers K. Klein E.A. Castagnino P. Assoian R.K. Dev. Cell. 2003; 5: 273-284Abstract Full Text PDF PubMed Scopus (46) Google we whether protein kinase activation cyclin D1 expression and G1-to-S-phase transition of endothelial cells. of endothelial cells, were at the phase of the cell cycle by serum with showed an after D1 expression to G1 phase cell cycle progression and was enhanced after treatment and by the PKC These showed that PKC activation cyclin D1 expression and subsequent G1 phase progression of endothelial cells, through PKC-mediated exclusion of LIMK2 from the nucleus, and suppression of cyclin D1 expression. Activation of of phosphorylation of Ser-283 of LIMK2 might the kinase activity of LIMK2 the enzyme to cells were stimulated with PMA, and the phosphorylation of LIMKs at LIMK and phosphorylation of cofilin were in to not phosphorylation of LIMK and cofilin phosphorylation in endothelial cells and not the PKC-mediated phosphorylation of LIMK2 the nucleocytoplasmic shuttling of LIMK2 but not kinase activity In this study, we a of PKC in the regulation of nucleocytoplasmic shuttling of LIMK2 in endothelial cells. PKC LIMK2 at thereby the of LIMK2 from the cytoplasm to the nucleus. in the nuclear The nuclear import and export of are by amino and D. U. Cell Dev. Biol. 1999; PubMed Scopus Google are also present in LIMK1 N. Mizuno K. Biochem. J. 1999; PubMed Scopus (46) Google Scholar). it has been that LIMK1 has two NES at the of the PDZ domain and one NLS in the kinase domain. LMB treatment, LIMK1 was predominantly localized in the nucleus, that it shuttles between the nucleus and the cytoplasm (19Roovers K. Klein E.A. Castagnino P. Assoian R.K. Dev. Cell. 2003; 5: 273-284Abstract Full Text PDF PubMed Scopus (46) Google Scholar, N. Mizuno K. Biochem. J. 1999; PubMed Scopus (46) Google Scholar). We that to LIMK2 was exclusively present in the nucleus of endothelial cells, that LIMK2 also shuttles between the nucleus and the The of NES and NLS in LIMK2 was by and analysis of the kinase domain of LIMK2 in endothelial cells. both LIMK1 and LIMK2 between the nucleus and the we showed a of the two kinases in their regulation of shuttling. we found PKC phosphorylation sites in LIMK1 in to and we showed that PKC activation the nucleocytoplasmic shuttling of LIMK2 but not LIMK1. we that the two LIM domains inhibit the nuclear import of LIMK2 but not the localization of the PDZ kinase LIM domains of but not was in the nucleus. from that LIM domains of LIMK1 with the kinase domain and that the domain inhibits the kinase activity J. Okano I. Higuchi O. N. Mizuno K. 1996; PubMed Scopus Google Scholar, D.C. Gill G.N. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). Our that the LIM domains to the kinase domain of LIMK2 and LIMK1 the NLS of LIMK2 but not LIMK1. In mouse the LIMK2 isoform is both LIM domains and is present mainly in the nucleus (15Nunoue K. Ohashi K. Okano I. Mizuno K. Oncogene. 1995; 11: 701-710PubMed Google Scholar, 16Ikebe C. Ohashi K. Mizuno K. Biochem. Biophys. Res. Commun. 1998; 246: 307-312Crossref PubMed Scopus (18) Google Scholar). This is in with that of the two LIM domains enhanced the nuclear localization of LIMK2. We predicted two PKC phosphorylation sites in one at Ser-283 the PDZ and the kinase and the other at Thr-494 the kinase domain, to the predicted We showed that activation of PKC inhibited the nuclear localization of the PDZ kinase construct of in the localization of the kinase domain of LIMK2 was This that PKC the nucleocytoplasmic shuttling of through Ser-283 phosphorylation. we were to that this site of LIMK2 was phosphorylated by PKC in as as in endothelial cells as PKC phosphorylated recombinant LIMK2. the various PKC PKC-δ was as the PKC-δ phosphorylation of LIMK2 but not LIMK2. PKC-mediated phosphorylation was for the LIMK2 as as for LIMK2 We that Ser-283 but not Thr-494 was the phosphorylation site of LIMK2. as as the Ser-283 site of it was that phosphorylation of this site regulated nucleocytoplasmic shuttling of LIMK2. between of nuclear export of the nuclear import of LIMK2 by PKC, studies the nuclear export LMB were We found a of nuclear of LIMK2 after and of the of LIMK2. These indicated that phosphorylation of Ser-283 by PKC inhibits the nuclear import of LIMK2. is the of PKC-mediated of LIMK2 from the cytoplasm to the Recently, it has been reported that nuclear localization of LIMKs Rac/Cdc42-mediated cyclin D1 expression. the suppression of cyclin D1 expression by nuclear LIMKs was independent of the effect of LIMKs on cofilin phosphorylation and regulation of actin dynamics (19Roovers K. Klein E.A. Castagnino P. Assoian R.K. Dev. Cell. 2003; 5: 273-284Abstract Full Text PDF PubMed Scopus (46) Google Scholar). D1 a in the progression of cells through the G1 phase of the cell cycle P. S. Oncogene. Google Scholar, D. M. H. S. Cell. Biol. 1994; PubMed Scopus Google and cyclin D1 expression is by as PKC 1994; PubMed Scopus Google Scholar, J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). We that serum stimulation of endothelial cells also inhibited nuclear import LIMK2 by protein kinase phosphorylation at Ser-283. Serum and stimulated G1-to-S-phase transition of endothelial cells, was by protein kinase stimulation of cyclin D1 expression. to suggest that PKC-mediated nuclear exclusion of LIMK2 might be a mechanism to relieve the suppression of cyclin D1 expression, thereby cell cycle progression. PKC-mediated phosphorylation of LIMK2 regulate nucleocytoplasmic nucleocytoplasmic shuttling as kinase protein kinase and cyclin are phosphorylated their NLS, thereby their to the protein M. H. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar, M. Nature. 1998; PubMed Scopus Google Scholar, J. R. S. J. Cell Biol. 1999; PubMed Scopus Google Scholar). Ser-283 is from the predicted NLS in the of that Ser-283 phosphorylation is not the of NLS of LIMK2 to LIMK2 phosphorylated at Ser-283 might as the This protein has been to to nucleocytoplasmic shuttling after their phosphorylation and to their NLS, thereby in the cytoplasm A. A. P. J. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, S. H. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). The of is We and for and to We are to for in of the with

References

38